Italy funds "cold plasma" sterilisation research
This article was originally published in Clinica
Executive Summary
Research into new medical device sterilisation technology is among the areas to benefit from the latest round of funding to be provided under the Italian government's applied research programme. "Cold plasma treatment of medical devices" is the subject of the project lead by Falc Instruments, an Italian small-to-medium sized company based in Lurano, Bergamo, according to the notice published in the Gazzetta Ufficiale of January 24. The project, budgeted at Lit2.93 billion ($1.3 million), is due to end in October 2003.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.